Report #2846740

Received Jun 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Recovered
Vaccinated: Apr 17, 2025
Onset: Apr 17, 2025
Days to onset: 0
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
PNC21	PNEUMO (CAPVAXIVE)	MERCK & CO. INC.	UNK	Y019158	OT / LA
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	EK225	OT

Symptoms (3)

ErythemaPain in extremitySkin warm

Symptom narrative

red, hot painful arm; red, hot painful arm; red, hot painful arm; Information has been received from the Food and Drug Administration (FDA) (agency number 2836907-1). This spontaneous report refers to a 65-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 17-Apr-2025, the patient was vaccinated with Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE), lot #Y019158, expiration date: 20-May-2026, administered by intramuscular route in the left arm for prophylaxis; and with Shingrix (Varicella zoster vaccine rgE (CHO)), lot #EK225, administered by intramuscular route (indication and expiration date were not reported). On 17-Apr-2025, the patient experienced red, hot painful arm (Skin warm, Pain in extremity, Erythema). On an unspecified date the patient recovered from the event of red, hot painful arm. The causal relationship between the events and the suspect therapies was not provided.